Novo Nordisk (Germany) Technical Analysis

NOVA Stock  EUR 100.50  0.50  0.50%   
As of the 29th of November, Novo Nordisk secures the Risk Adjusted Performance of (0.13), standard deviation of 1.74, and Mean Deviation of 1.35. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Novo Nordisk AS, as well as the relationship between them. Please verify Novo Nordisk AS mean deviation, standard deviation, information ratio, as well as the relationship between the coefficient of variation and variance to decide if Novo Nordisk AS is priced some-what accurately, providing market reflects its recent price of 100.5 per share.

Novo Nordisk Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Novo, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Novo
  
Novo Nordisk's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Novo Nordisk technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Novo Nordisk technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Novo Nordisk trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Novo Nordisk AS Technical Analysis

Indicator
Time Period
Execute Indicator
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Novo Nordisk AS volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Novo Nordisk AS Trend Analysis

Use this graph to draw trend lines for Novo Nordisk AS. You can use it to identify possible trend reversals for Novo Nordisk as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Novo Nordisk price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Novo Nordisk Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Novo Nordisk AS applied against its price change over selected period. The best fit line has a slop of   0.38  , which may suggest that Novo Nordisk AS market price will keep on failing further. It has 122 observation points and a regression sum of squares at 5432.52, which is the sum of squared deviations for the predicted Novo Nordisk price change compared to its average price change.

About Novo Nordisk Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Novo Nordisk AS on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Novo Nordisk AS based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Novo Nordisk AS price pattern first instead of the macroeconomic environment surrounding Novo Nordisk AS. By analyzing Novo Nordisk's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Novo Nordisk's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Novo Nordisk specific price patterns or momentum indicators. Please read more on our technical analysis page.

Novo Nordisk November 29, 2024 Technical Indicators

Most technical analysis of Novo help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Novo from various momentum indicators to cycle indicators. When you analyze Novo charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Novo Nordisk November 29, 2024 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Novo stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

Complementary Tools for Novo Stock analysis

When running Novo Nordisk's price analysis, check to measure Novo Nordisk's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novo Nordisk is operating at the current time. Most of Novo Nordisk's value examination focuses on studying past and present price action to predict the probability of Novo Nordisk's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novo Nordisk's price. Additionally, you may evaluate how the addition of Novo Nordisk to your portfolios can decrease your overall portfolio volatility.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios